Latest Blog Posts
Navigating MDR: Fresh Insights and Updates

2026 Starts with a High-Level of Legal Uncertainty for AI/Ml-Enabled Medical Devices
Summary AI Regulation for AI-enabled medical devices is entering a period of significant change. While the European Commission has proposed measures to simplify the regulatory

GDPR’s New Direction: What MedTech Needs to Know
Summary The European Commission’s proposed Digital Omnibus package could significantly reshape how the GDPR applies to medical device manufacturers, particularly those developing Software as a

Automating Regulatory Compliance: The Future of Quality and Regulatory?
Summary Artificial intelligence is rapidly becoming part of the quality and regulatory landscape. From drafting procedures and technical documentation to auditing management systems and analysing

prEN 18286, future of the EU’s AI management system standard
Summary Update, October 2026: Since this article was written, the draft has been published as EN 18286:2026, and the Commission has referenced it in the

Meet the Team: Lauren Perez
At MedQAIR, we know that strong regulatory and quality systems are built on both experience and continuous learning. As medical devices, software, and AI-enabled technologies

Cybersecurity Resilience Act (CRA, 2024/2847) and Health Software
Summary Cybersecurity has become a central topic across the European digital regulatory landscape. While medical device manufacturers have already been navigating cybersecurity requirements under the

AI Act Section A to B: Minimal change or far-reaching consequences?
Summary The European Parliament’s proposal to move product-regulated AI systems from Section A to Section B of the AI Act may initially sound like a

Article 5(5) Redesigned: Sharing In-House Medical Software Across Hospitals
Summary When the MDR and IVDR entered into force, Article 5(5) created a specific framework for medical devices developed and used within health institutions. The

AI/ML Systems, preparing an FDA submission Part III: ‘The submission’
Summary By the time teams reach the submission phase, the assumption is often that the hardest decisions are behind them. In Part III, Leon challenges